Back to search

Aristotle University Of Thessaloniki (AUTH)

Ο ρόλος της ελλιπούς γαλακτοζυλίωσης της IgA1 ανοσοσφαιρίνης στην παθογένεια κλινική εικόνα και εξέλιξη της IgA νεφροπάθειας

Abstract

dc:description

Aim of the present study was to investigate whether the determination of the galactose-deficient IgA1 levels and the expression of miRNAs let-7b and miR-148b could contribute to the diagnosis of IgA nephropathy before performing a renal biopsy, or if they could act as a prognostic marker of progression and response to therapy in patients with established IgA nephropathy. We studied 95 patients with biopsy proven IgA nephropathy (mean follow up: 8,7 ± 5,8 years) and two control groups consisting of 87 healthy volunteers and 65 patients with other glomerular diseases. The histological features were evaluated using the Oxford classification of IgA nephropathy. The galactose-deficient IgA1 levels were measured using an ELISA method based on the monoclonal antibody KM55, that recognises as epitope the hinge region of galactose-deficient IgA1. The expression of miRNAs let-7b and miR-148b was determined using real-time quantitative PCR. Galactose-deficient IgA1 levels and the let-7b expression were significantly higher at the time of renal biopsy in patients with IgA nephropathy than in healthy volunteers (p<0,001) and in patients with other glomerular diseases (p<0,001), while they were similar in healthy volunteers and in patients with other glomerular diseases (ns). A higher expression of both let-7b and miR-148b was documented in patients with episodes of macroscopic haematuria (p<0,001 and p=0,06 respectively). The presence of crescents had a negative correlation with the levels of galactose-deficient IgA1, let-7b and miR-148b (p=0,028, p=0,002 and p=0,015 respectively). Higher let-7b expression was documented in patients with faster deterioration of renal function (higher annual decline of eGFR, p=0,01), in patients who started dialysis (p=0,001) and in patients who reached the combined endpoint of the study (≥50% reduction of eGFR at the end of follow-up compared to baseline or start of dialysis, p=0,001). Furthermore, the let-7b expression influenced the renal survival in the Cox regression analysis (p=0.015). The impact of let-7b on the outcome of renal function was more prominent in patients treated with corticosteroids (p=0,007). The levels of galactose-deficient IgA1 were significantly lower at the end of follow up (9,9 ± 7,2 μg/ml) than at the time of renal biopsy (18,7 ± 12,4 μg/ml, p<0,001). This reduction was more prominent among the patients that received immunosuppressive therapy (p<0,001) than in the rest of the patients΄ cohort (p=0,023). In conclusion, despite the fact that the method for the determination of galactose-deficient IgA1 based on the antibody KM55 is far more stable than the older lectin-based methods, the limitation still remains that slightly elevated levels can be found in healthy individuals or in other glomerular diseases. The specificity and sensibility of the method could not allow a diagnosis of IgA nephropathy based solely on galactose-deficient IgA1 levels without the use of renal biopsy. This applies also to the elevated levels of let-7b found in IgA patients. On the other hand, let-7b expression at the time of renal biopsy predicted the long-term outcome of renal function and identified patients resistant even to aggressive treatment with immunosuppressives.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kouri, Nikoletta-Maria
  • Κουρή, Νικολέττα-Μαρία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50995

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kouri, Nikoletta-Maria; Κουρή, Νικολέττα-Μαρία. Ο ρόλος της ελλιπούς γαλακτοζυλίωσης της IgA1 ανοσοσφαιρίνης στην παθογένεια κλινική εικόνα και εξέλιξη της IgA νεφροπάθειας. Aristotle University Of Thessaloniki (AUTH), 2022. http://hdl.handle.net/10442/hedi/50995